Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention China, the most common co-covered peer. The tracked stories average 2 original sources each. Marie Roseline Belizaire appears in 1 tracked Biotech story from July 12, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Marie Roseline Belizaire
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention China, the most common co-covered peer. The tracked stories average 2 original sources each. Marie Roseline Belizaire appears in 1 tracked Biotech story from July 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Marie Roseline Belizaire. Shared-story counts are live from our verified record — not editorial picks.
75 healthcare workers infected with the Ebola Bundibugyo strain in DRC expose critical gaps in vaccine coverage and trial infrastructure, pressuring biopharma to accelerate strain-specific countermeasures.